
Europe • Euronext Dublin • DUB:UPR • IE00BJ5FQX74
The current stock price of UPR.I is 4.015 EUR. In the past month the price increased by 8.97%. In the past year, price increased by 70.64%.
ChartMill assigns a technical rating of 10 / 10 to UPR.I. When comparing the yearly performance of all stocks, UPR.I is one of the better performing stocks in the market, outperforming 86.85% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to UPR.I. While UPR.I belongs to the best of the industry regarding profitability, there are concerns on its financial health.
Over the last trailing twelve months UPR.I reported a non-GAAP Earnings per Share(EPS) of 0.22. The EPS increased by 16.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.3% | ||
| ROA | 4.25% | ||
| ROE | 17.78% | ||
| Debt/Equity | 1.21 |
12 analysts have analysed UPR.I and the average price target is 4.93 EUR. This implies a price increase of 22.81% is expected in the next year compared to the current price of 4.015.
For the next year, analysts expect an EPS growth of 14.54% and a revenue growth 8.68% for UPR.I
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AXNA | AMPLIFON SPA | 18.87 | 3.216B | ||
| AMP | AMPLIFON SPA | 18.78 | 3.16B | ||
| FAGR | FAGRON | 14.54 | 1.617B | ||
| ILM1 | MEDIOS AG | 11.86 | 419.384M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 11.54 | 165.088M | ||
| VME | VIROMED MEDICAL AG | N/A |
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Dublin Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
UNIPHAR PLC
4045 Kingswood Road, Citywest Business Park
DUBLIN DUBLIN IE
Employees: 3500
Phone: 35314687501
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. The firm is focused on improving access to pharmaco-medical products and therapies. The company operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. Its Uniphar Medtech division provides outsourced services, specifically sales, distribution, and support services to medical device manufacturers. Uniphar Pharma division operates a global business with valued services across the lifecycle of a pharmaceutical product. This division operates through on demand and pharma services business units. Uniphar Supply Chain & Retail division provides both pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons in Ireland. The company operates a network of pharmacies under the Life, Allcare, Hickey’s and McCauleys brands. The company also provides services and support that help independent community pharmacies.
The current stock price of UPR.I is 4.015 EUR. The price decreased by -0.37% in the last trading session.
UNIPHAR PLC (UPR.I) has a dividend yield of 0.87%. The yearly dividend amount is currently 0.02.
UPR.I has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
The PE ratio for UNIPHAR PLC (UPR.I) is 18.25. This is based on the reported non-GAAP earnings per share of 0.22 and the current share price of 4.015 EUR.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on UPR.I.